INS and obesity due to melanocortin 4 receptor deficiency: Obesity impairs insulin signaling via chronic inflammation, lipotoxicity, and metabolic dysregulation [16], while the synergy of obesity and IR promotes age-related comorbidities (e.g., DM, CVD) that exacerbate systemic frailty [17].